BL is derived from a germinal center derived lymphoma, exhibiting BCL6, CD10, CD19, CD20, CD22, and CD79a expression and lacking CD5, BCL2, TdT, and, typically, CD23. Here, BCL2 is linked to Burkitt lymphoma.